BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 35732988)

  • 1. PET/MR Imaging of a Lung Metastasis Model of Clear Cell Renal Cell Carcinoma with (2S,4R)-4-[
    Pollard AC; Paolillo V; Radaram B; Qureshy S; Li L; Maity T; Wang L; Uddin MN; Wood CG; Karam JA; Pagel MD; Piwnica-Worms D; Millward SW; Fowlkes NW; Norton W; Engel BJ; Pisaneschi F; Zacharias NM
    Mol Imaging Biol; 2022 Dec; 24(6):959-972. PubMed ID: 35732988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic Evaluation of MYCN-Amplified Neuroblastoma by 4-[
    Li C; Huang S; Guo J; Wang C; Huang Z; Huang R; Liu L; Liang S; Wang H
    Mol Imaging Biol; 2019 Dec; 21(6):1117-1126. PubMed ID: 30850970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploiting Glutamine Consumption in Atherosclerotic Lesions by Positron Emission Tomography Tracer (2
    Palani S; Miner MWG; Virta J; Liljenbäck H; Eskola O; Örd T; Ravindran A; Kaikkonen MU; Knuuti J; Li XG; Saraste A; Roivainen A
    Front Immunol; 2022; 13():821423. PubMed ID: 35145523
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PET imaging of glutaminolysis in tumors by 18F-(2S,4R)4-fluoroglutamine.
    Lieberman BP; Ploessl K; Wang L; Qu W; Zha Z; Wise DR; Chodosh LA; Belka G; Thompson CB; Kung HF
    J Nucl Med; 2011 Dec; 52(12):1947-55. PubMed ID: 22095958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging Brain Metastasis Patients With 18F-(2S,4R)-4-Fluoroglutamine.
    Xu X; Zhu H; Liu F; Zhang Y; Yang J; Zhang L; Zhu L; Li N; Kung HF; Yang Z
    Clin Nucl Med; 2018 Nov; 43(11):e392-e399. PubMed ID: 30179907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preclinical Evaluation of 4-[18F]Fluoroglutamine PET to Assess ASCT2 Expression in Lung Cancer.
    Hassanein M; Hight MR; Buck JR; Tantawy MN; Nickels ML; Hoeksema MD; Harris BK; Boyd K; Massion PP; Manning HC
    Mol Imaging Biol; 2016 Feb; 18(1):18-23. PubMed ID: 25971659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative enzymology of (2S,4R)4-fluoroglutamine and (2S,4R)4-fluoroglutamate.
    Cooper AJ; Krasnikov BF; Pinto JT; Kung HF; Li J; Ploessl K
    Comp Biochem Physiol B Biochem Mol Biol; 2012 Sep; 163(1):108-20. PubMed ID: 22613816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic Assessment of
    Grkovski M; Goel R; Krebs S; Staton KD; Harding JJ; Mellinghoff IK; Humm JL; Dunphy MPS
    J Nucl Med; 2020 Mar; 61(3):357-366. PubMed ID: 31601700
    [No Abstract]   [Full Text] [Related]  

  • 9. PET Imaging of
    Liu F; Xu X; Zhu H; Zhang Y; Yang J; Zhang L; Li N; Zhu L; Kung HF; Yang Z
    Mol Pharm; 2018 Aug; 15(8):3448-3455. PubMed ID: 29985631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In Vivo PET Assay of Tumor Glutamine Flux and Metabolism: In-Human Trial of
    Dunphy MPS; Harding JJ; Venneti S; Zhang H; Burnazi EM; Bromberg J; Omuro AM; Hsieh JJ; Mellinghoff IK; Staton K; Pressl C; Beattie BJ; Zanzonico PB; Gerecitano JF; Kelsen DP; Weber W; Lyashchenko SK; Kung HF; Lewis JS
    Radiology; 2018 May; 287(2):667-675. PubMed ID: 29388903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of (2S,4S)-4-[
    Huang Y; Liu Y; Li C; Li Z; Chen H; Zhang L; Liang Y; Wu Z
    Mol Pharm; 2023 Oct; 20(10):5195-5205. PubMed ID: 37647563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [
    Seo Y; Craig MC; Murphy ST; Feng J; Chen X; Yuneva M
    Mol Imaging; 2022; 2022():5185951. PubMed ID: 35967756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (2S, 4R)-4-[
    Miner MW; Liljenbäck H; Virta J; Merisaari J; Oikonen V; Westermarck J; Li XG; Roivainen A
    Mol Imaging Biol; 2020 Aug; 22(4):969-978. PubMed ID: 31993927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. KRAS Mutation Detection with (2
    Liu S; Liu F; Hou X; Zhang Q; Ren Y; Zhu H; Yang Z; Xu X
    Mol Pharm; 2024 Apr; 21(4):2034-2042. PubMed ID: 38456403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dynamic PET/CT imaging of
    Xu X; Zhu H; Liu F; Zhang Y; Yang J; Zhang L; Xie Q; Zhu L; Li N; Kung HF; Yang Z
    Eur J Nucl Med Mol Imaging; 2020 Sep; 47(10):2280-2292. PubMed ID: 32166510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glutamine Addiction in Kidney Cancer Suppresses Oxidative Stress and Can Be Exploited for Real-Time Imaging.
    Abu Aboud O; Habib SL; Trott J; Stewart B; Liang S; Chaudhari AJ; Sutcliffe J; Weiss RH
    Cancer Res; 2017 Dec; 77(23):6746-6758. PubMed ID: 29021138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of: (2
    Miner MWG; Liljenbäck H; Virta J; Helin S; Eskola O; Elo P; Teuho J; Seppälä K; Oikonen V; Yang G; Kindler-Röhrborn A; Minn H; Li XG; Roivainen A
    Front Oncol; 2021; 11():730358. PubMed ID: 34692505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alanine and glycine conjugates of (2S,4R)-4-[
    Zha Z; Ploessl K; Lieberman BP; Wang L; Kung HF
    Nucl Med Biol; 2018 May; 60():19-28. PubMed ID: 29525446
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [
    Valtorta S; Toscani D; Chiu M; Sartori A; Coliva A; Brevi A; Taurino G; Grioni M; Ruffini L; Vacondio F; Zanardi F; Bellone M; Moresco RM; Bussolati O; Giuliani N
    Front Oncol; 2021; 11():760732. PubMed ID: 34712616
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.